Efficacy and Safety of Laparoscopic Lateral Suspension and Transvaginal Sacrospinous Ligament Fixation in Patients With Pelvic Organ Prolapse

Phase

N/A

Condition

Genitourinary Prolapse

Treatment

Transvaginal sacrospinous ligament fixation

laparoscopic lateral suspension

Clinical Study ID

NCT06903988

2024PHB374-002

Ages > 18
Female

Study Summary

This study is a single-center, non-blinded, non-inferiority randomized controlled trial, planning to recruit 86 patients with Stage III or higher pelvic organ prolapse who are unresponsive to conservative treatment and are requesting surgical treatment. Patients who meet the inclusion and exclusion criteria will be randomly assigned to the transvaginal sacrospinous ligament fixation group and the laparoscopic lateral suspension group in a 1:1 ratio. Follow-ups will be conducted at 1 month, 3 months, 6 months, and 1 year after surgery for the enrolled patients. The primary outcome measure is the difference in surgical success rate between the two groups of patients at 1 year after surgery. We hypothesize that the surgical success rate of laparoscopic lateral suspension is not inferior to that of transvaginal sacrospinous ligament fixation

Eligibility Criteria

Inclusion

Inclusion Criteria:

Age ≥ 18 years;
According to the POP-Q classification, patients who meet any of the followingconditions: a. Patients with anterior wall prolapse of stage III or higher; b.Patients with apical prolapse of stage III or higher;
Patients who refuse conservative treatment or have ineffective conservativetreatment and request surgical treatment for prolapse;
Patients who voluntarily participate in this study, sign the informed consent form,and are able to attend follow-up visits on time;
Patients who have received education at the primary school level or above;
Patients who are able to visit the hospital for examinations;
Patients who are deemed fit to undergo surgery according to preoperative anesthesiaassessment.

Exclusion

Exclusion Criteria:

Patients who have previously undergone surgery for pelvic organ prolapse (POP);
Patients with a history of anti-incontinence surgery or who are planned to undergomid-urethral sling surgery for anti-incontinence during the current operation;
Patients who, after evaluation by the surgeon, have other conditions that affecteligibility for inclusion.

Study Design